Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration
- 1 January 2020
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (1) , 191-205
Abstract
No abstract availableKeywords
Funding Information
- the National Institutes of Health (R01CA173292)
- The University of Kansas
This publication has 182 references indexed in Scilit:
- Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic MicePharmaceutical Research, 2011
- Mast cell proteases and inflammationDrug Discovery Today: Disease Models, 2011
- Neonatal Fc Receptor: From Immunity to TherapeuticsJournal of Clinical Immunology, 2010
- Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor BindingMolecular & Cellular Proteomics, 2010
- Proteomic Identification of Carbonylated Proteins and Their Oxidation SitesJournal of Proteome Research, 2010
- Hydrogen peroxide is the major oxidant product of xanthine oxidaseFree Radical Biology and Medicine, 2010
- Skin-Resident T Cells: The Ups and Downs of On Site ImmunityJournal of Investigative Dermatology, 2010
- Expression and function of matrix metalloproteinase (MMP)-28Matrix Biology, 2009
- Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRnProtein Science, 2009
- Lymphatic-specific expression of dipeptidyl peptidase IV and its dual role in lymphatic endothelial functionExperimental Cell Research, 2008